Treating Severe Vitamin B12 Deficiency
US$ 25.16
intravenous glutathione skin whitening randomized controlled trial for lightening: a regnant myth or evidence-based verity? Systematic Review of the Efficacy
Description
developed a controlled-release nanodroplet targeting CAFs by co-delivering the ASCT2 (SLC1A5) inhibitor V9302 and GLULsiRNA (siGLUL) to CAFs
The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells
Other Peptides: What Sets It Apart
Caccuri, F
